本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Keros Therapeutics, Inc.

14.40
-0.0450-0.31%
成交量:30.70万
成交额:441.63万
市值:5.84亿
市盈率:-2.88
高:14.45
开:14.39
低:14.18
收:14.44
数据加载中...
2021/03/25

重要事件披露

8-K - Current report
2021/03/05

重要事件披露

8-K - Current report
2021/03/02

重要事件披露

8-K - Current report
2021/02/17

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/12/21

重要事件披露

8-K - Current report
2020/12/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/12/17

重要事件披露

8-K - Current report
2020/12/07

重要事件披露

8-K - Current report
2020/11/25

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/20

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/17

重要事件披露

8-K - Current report
2020/11/13

重要事件披露

8-K - Current report
2020/11/10

SEC问询函

CORRESP [Cover] - Correspondence